{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:39:28Z","timestamp":1787020768580,"version":"build-2736575974"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,10]],"date-time":"2025-05-10T00:00:00Z","timestamp":1746835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,10]],"date-time":"2025-05-10T00:00:00Z","timestamp":1746835200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Ovarian Res"],"DOI":"10.1186\/s13048-025-01657-8","type":"journal-article","created":{"date-parts":[[2025,5,10]],"date-time":"2025-05-10T03:55:02Z","timestamp":1746849302000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Malignant ascites in ovarian cancer is compatible with long-term (10 year) survival with associations to clinicopathological features"],"prefix":"10.1186","volume":"18","author":[{"given":"Lok Hang","family":"Chow","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annabelle M. Y.","family":"Ngai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheuk-yin","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline H. S.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfred L. H.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua J. X.","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip P. C.","family":"Ip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,10]]},"reference":[{"key":"1657_CR1","doi-asserted-by":"crossref","unstructured":"Meena RK, Syed NA, Sheikh ZA, Guru FR, Mir MH, Banday SZ et al. Patterns of treatment and outcomes in epithelial ovarian cancer: A retrospective North Indian Single-Institution experience. JCO Global Oncol. 2022(8):e2200032.","DOI":"10.1200\/GO.22.00032"},{"issue":"22","key":"1657_CR2","doi-asserted-by":"publisher","first-page":"2705","DOI":"10.1001\/jama.291.22.2705","volume":"291","author":"BA Goff","year":"2004","unstructured":"Goff BA, Mandel LS, Melancon CH, Muntz HG. Frequency of symptoms of ovarian cancer in women presenting to primary care clinics. JAMA. 2004;291(22):2705\u201312.","journal-title":"JAMA"},{"issue":"1","key":"1657_CR3","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1177\/1049909120928980","volume":"38","author":"V Ramamoorthy","year":"2021","unstructured":"Ramamoorthy V, Rubens M, Saxena A, Bhatt C, Das S, Appunni S, et al. Prevalence and inpatient hospital outcomes of Malignancy-Related Ascites in the united States. Am J Hospice Palliat Medicine\u00ae. 2021;38(1):47\u201353.","journal-title":"Am J Hospice Palliat Medicine\u00ae"},{"issue":"6","key":"1657_CR4","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1007\/s00520-018-4510-9","volume":"27","author":"MJA Rietveld","year":"2019","unstructured":"Rietveld MJA, Husson O, Vos MC, van de Poll-Franse LV, Ottevanger PB, Ezendam NPM. Presence of gastro-intestinal symptoms in ovarian cancer patients during survivorship: a cross-sectional study from the PROFILES registry. Support Care Cancer. 2019;27(6):2285\u201393.","journal-title":"Support Care Cancer"},{"key":"1657_CR5","doi-asserted-by":"crossref","unstructured":"Pitiyarachchi O, Friedlander M, Java JJ, Chan JK, Armstrong DK, Markman M, et al.What proportion of patients with stage 3 ovarian cancer are potentially cured following intraperitoneal chemotherapy? Analysis of the long term (\u226510 years) survivors in NRG\/GOG randomized clinical trials of intraperitoneal and intravenous chemotherapy in stage III ovarian cancer. Gynecologic Oncology. 2022;166(3):410-6.","DOI":"10.1016\/j.ygyno.2022.07.004"},{"key":"1657_CR6","doi-asserted-by":"publisher","first-page":"115","DOI":"10.2147\/CMAR.S100210","volume":"9","author":"M Stukan","year":"2017","unstructured":"Stukan M. Drainage of malignant ascites: patient selection and perspectives. Cancer Manag Res. 2017;9:115\u201330.","journal-title":"Cancer Manag Res"},{"key":"1657_CR7","doi-asserted-by":"crossref","unstructured":"Berger JM, Preusser M, Berghoff AS, Bergen ES. Malignant ascites: current therapy options and treatment prospects. Cancer Treat Rev. 2023;121.","DOI":"10.1016\/j.ctrv.2023.102646"},{"issue":"3","key":"1657_CR8","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1097\/AOG.0b013e318264f794","volume":"120","author":"LA Baldwin","year":"2012","unstructured":"Baldwin LA, Huang B, Miller RW, Tucker T, Goodrich ST, Podzielinski I, et al. Ten-year relative survival for epithelial ovarian cancer. Obstet Gynecol. 2012;120(3):612\u20138.","journal-title":"Obstet Gynecol"},{"key":"1657_CR9","first-page":"1","volume-title":"The international system for serous fluid cytopathology","author":"B Crothers","year":"2020","unstructured":"Crothers B, Baloch Z, Chandra A, Farahani S, Kurtycz D, Schmitt F. The international system for reporting serous fluid cytopathology: introduction and overview of diagnostic terminology and reporting. In: Chandra A, Crothers B, Kurtycz D, Schmitt F, editors. The international system for serous fluid cytopathology. Cham: Springer International Publishing; 2020. pp. 1\u20137."},{"issue":"16","key":"1657_CR10","doi-asserted-by":"publisher","first-page":"3080","DOI":"10.1002\/cncr.34350","volume":"128","author":"C Marth","year":"2022","unstructured":"Marth C, Abreu MH, Andersen KK, Aro KM, de Lurdes Batarda M, Boll D, et al. Real-life data on treatment and outcomes in advanced ovarian cancer: an observational, multinational cohort study (RESPONSE trial). Cancer. 2022;128(16):3080\u20139.","journal-title":"Cancer"},{"issue":"5","key":"1657_CR11","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1093\/annonc\/mdl499","volume":"18","author":"AA Ayantunde","year":"2007","unstructured":"Ayantunde AA, Parsons SL. Pattern and prognostic factors in patients with malignant ascites: a retrospective study. Ann Oncol. 2007;18(5):945\u20139.","journal-title":"Ann Oncol"},{"issue":"4","key":"1657_CR12","doi-asserted-by":"publisher","first-page":"e40","DOI":"10.3802\/jgo.2017.28.e40","volume":"28","author":"K Nagamine","year":"2017","unstructured":"Nagamine K, Kondo J, Kaneshiro R, Tauchi-Nishi P, Terada K. Ovarian needle aspiration in the diagnosis and management of ovarian masses. J Gynecol Oncol. 2017;28(4):e40.","journal-title":"J Gynecol Oncol"},{"issue":"7","key":"1657_CR13","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1097\/GME.0000000000001534","volume":"27","author":"S Baransi","year":"2020","unstructured":"Baransi S, Michaan N, Gortzak-Uzan L, Aizic A, Laskov I, Gamzu R, et al. The accuracy of Ascites cytology in diagnosis of advanced ovarian cancer in postmenopausal women prior to neoadjuvant chemotherapy. Menopause. 2020;27(7):771\u20135.","journal-title":"Menopause"},{"issue":"4","key":"1657_CR14","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1159\/000529855","volume":"67","author":"JKM Ng","year":"2023","unstructured":"Ng JKM, Chow LH, Ngai AMY, Chan RCK, Lee JHS, Lee ALH, et al. Number needed to diagnose in malignant ascites: effects of volume, repeating collection, and primary malignancy on diagnostic performance in peritoneal fluid cytology. Acta Cytol. 2023;67(4):434\u201343.","journal-title":"Acta Cytol"},{"issue":"4","key":"1657_CR15","doi-asserted-by":"publisher","first-page":"87","DOI":"10.4240\/wjgs.v4.i4.87","volume":"4","author":"SL Sangisetty","year":"2012","unstructured":"Sangisetty SL, Miner TJ. Malignant ascites: A review of prognostic factors, pathophysiology and therapeutic measures. World J Gastrointest Surg. 2012;4(4):87\u201395.","journal-title":"World J Gastrointest Surg"},{"key":"1657_CR16","doi-asserted-by":"crossref","unstructured":"Kadono T, Ishiki H, Yokomichi N, Ito T, Maeda I, Hatano Y et al. Malignancy-related Ascites in palliative care units: prognostic factor analysis. BMJ Supportive Palliat Care. 2023:spcare\u20132023.","DOI":"10.1136\/spcare-2023-004286"},{"issue":"5","key":"1657_CR17","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/S0959-8049(99)00011-8","volume":"35","author":"CK Lee","year":"1999","unstructured":"Lee CK, Pires de Miranda M, Ledermann JA, Ruiz de Elvira MC, Nelstrop AE, Lambert HE, et al. Outcome of epithelial ovarian cancer in women under 40 years of age treated with platinum-based chemotherapy. Eur J Cancer. 1999;35(5):727\u201332.","journal-title":"Eur J Cancer"},{"key":"1657_CR18","doi-asserted-by":"publisher","first-page":"viii51","DOI":"10.1093\/annonc\/mdx441","volume":"28","author":"S Pignata","year":"2017","unstructured":"Pignata S, Cecere C, Du Bois S, Harter A, Heitz P. Treatment of recurrent ovarian cancer. Ann Oncol. 2017;28:viii51\u20136.","journal-title":"Ann Oncol"},{"issue":"3","key":"1657_CR19","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1016\/j.ygyno.2014.02.038","volume":"133","author":"A Davis","year":"2014","unstructured":"Davis A, Tinker AV, Friedlander M. Platinum resistant ovarian cancer: what is it, who to treat and how to measure benefit? Gynecol Oncol. 2014;133(3):624\u201331.","journal-title":"Gynecol Oncol"},{"issue":"3","key":"1657_CR20","first-page":"111","volume":"3","author":"JO Schorge","year":"2010","unstructured":"Schorge JO, McCann C, Del Carmen MG. Surgical debulking of ovarian cancer: what difference does it make? Rev Obstet Gynecol. 2010;3(3):111\u20137.","journal-title":"Rev Obstet Gynecol"},{"issue":"3","key":"1657_CR21","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1007\/s12032-011-0019-5","volume":"29","author":"V Asher","year":"2012","unstructured":"Asher V, Lee J, Bali A. Preoperative serum albumin is an independent prognostic predictor of survival in ovarian cancer. Med Oncol. 2012;29(3):2005\u20139.","journal-title":"Med Oncol"},{"issue":"4","key":"1657_CR22","doi-asserted-by":"publisher","first-page":"2033","DOI":"10.21873\/invivo.12003","volume":"34","author":"T Fujii","year":"2020","unstructured":"Fujii T, Tokuda S, Nakazawa Y, Kurozumi S, Obayashi S, Yajima R, et al. Implications of low serum albumin as a prognostic factor of Long-term outcomes in patients with breast cancer. Vivo. 2020;34(4):2033\u20136.","journal-title":"Vivo"},{"issue":"6","key":"1657_CR23","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1001\/archinte.160.6.861","volume":"160","author":"A Vigan\u00f3","year":"2000","unstructured":"Vigan\u00f3 A, Bruera E, Jhangri GS, Newman SC, Fields AL, Suarez-Almazor ME. Clinical survival predictors in patients with advanced cancer. Arch Intern Med. 2000;160(6):861\u20138.","journal-title":"Arch Intern Med"},{"issue":"1","key":"1657_CR24","first-page":"1","volume":"16","author":"H Kaneko","year":"2022","unstructured":"Kaneko H, Shimura K, Yoshida M, Matsumoto Y, Kobayashi T, Uchiyama H, et al. Serum albumin levels strongly predict survival outcome of elderly patients with diffuse large B-Cell lymphoma treated with Rituximab-Combined chemotherapy. Int J Hematol Oncol Stem Cell Res. 2022;16(1):1\u20138.","journal-title":"Int J Hematol Oncol Stem Cell Res"},{"issue":"6","key":"1657_CR25","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.21037\/jtd-21-1649","volume":"14","author":"WC Kwok","year":"2022","unstructured":"Kwok WC, Ho JCM, Tam TCC, Ip MSM, Lam DCL. Serum protein level as a predictor of therapeutic response and adverse effects associated with Afatinib use. J Thorac Disease. 2022;14(6):1880\u20139.","journal-title":"J Thorac Disease"},{"key":"1657_CR26","doi-asserted-by":"publisher","first-page":"1323192","DOI":"10.3389\/fonc.2024.1323192","volume":"14","author":"Q Tang","year":"2024","unstructured":"Tang Q, Li X, Sun CR. Predictive value of serum albumin levels on cancer survival: a prospective cohort study. Front Oncol. 2024;14:1323192.","journal-title":"Front Oncol"},{"issue":"6","key":"1657_CR27","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.1093\/ajcn\/87.6.1678","volume":"87","author":"B Laky","year":"2008","unstructured":"Laky B, Janda M, Cleghorn G, Obermair A. Comparison of different nutritional assessments and body-composition measurements in detecting malnutrition among gynecologic cancer patients1. Am J Clin Nutr. 2008;87(6):1678\u201385.","journal-title":"Am J Clin Nutr"},{"issue":"5","key":"1657_CR28","doi-asserted-by":"publisher","first-page":"e115","DOI":"10.1371\/journal.pmed.0040115","volume":"4","author":"UE Schaible","year":"2007","unstructured":"Schaible UE, Kaufmann SH. Malnutrition and infection: complex mechanisms and global impacts. PLoS Med. 2007;4(5):e115.","journal-title":"PLoS Med"},{"issue":"1","key":"1657_CR29","first-page":"8824951","volume":"2021","author":"N Fentahun","year":"2021","unstructured":"Fentahun N, Anteneh Y, Menber Y. Malnutrition in the outcome of wound healing at public hospitals in Bahir Dar City, Northwest Ethiopia: A prospective cohort study. J Nutr Metabolism. 2021;2021(1):8824951.","journal-title":"J Nutr Metabolism"},{"key":"1657_CR30","doi-asserted-by":"publisher","first-page":"2","DOI":"10.4103\/ijpvm.ijpvm_9_22","volume":"14","author":"M Moosazadeh","year":"2023","unstructured":"Moosazadeh M, Espahbodi F, Afshari M, Eslami A. Can CBC profile and liver function test predict chronic kidney disease among a normal population?? Int J Prev Med. 2023;14:2.","journal-title":"Int J Prev Med"},{"issue":"4","key":"1657_CR31","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1097\/MPA.0000000000001262","volume":"48","author":"M Baretti","year":"2019","unstructured":"Baretti M, Pulluri B, Tsai HL, Blackford AL, Wolfgang CL, Laheru D, et al. The significance of Ascites in patients with pancreatic ductal adenocarcinoma: A Case-Control study. Pancreas. 2019;48(4):585\u20139.","journal-title":"Pancreas"},{"issue":"2","key":"1657_CR32","doi-asserted-by":"publisher","first-page":"247","DOI":"10.2169\/internalmedicine.5693-20","volume":"60","author":"M Chiba","year":"2021","unstructured":"Chiba M, Goto T, Sato W, Shibuya T, Takahashi K, Minami S, et al. Extremely late recurrence of ovarian carcinoma diagnosed by an endoscopic Ultrasound-guided Fine-needle biopsy. Intern Med. 2021;60(2):247\u201350.","journal-title":"Intern Med"},{"issue":"6","key":"1657_CR33","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.2214\/AJR.10.4302","volume":"195","author":"R Katre","year":"2010","unstructured":"Katre R, Morani AK, Prasad SR, Surabhi VR, Choudhary S, Sunnapwar A. Tumors and pseudotumors of the secondary m\u00fcllerian system: review with emphasis on Cross-Sectional imaging findings. Am J Roentgenol. 2010;195(6):1452\u20139.","journal-title":"Am J Roentgenol"},{"issue":"19","key":"1657_CR34","doi-asserted-by":"publisher","first-page":"4289","DOI":"10.1002\/cncr.33073","volume":"126","author":"BR Corr","year":"2020","unstructured":"Corr BR, Moroney M, Sheeder J, Eckhardt SG, Sawyer B, Behbakht K, et al. Survival and clinical outcomes of patients with ovarian cancer who were treated on phase 1 clinical trials. Cancer. 2020;126(19):4289\u201393.","journal-title":"Cancer"},{"key":"1657_CR35","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.critrevonc.2017.11.008","volume":"120","author":"E Moujaess","year":"2017","unstructured":"Moujaess E, Fakhoury M, Assi T, Elias H, El Karak F, Ghosn M, et al. The therapeutic use of human albumin in cancer patients\u2019 management. Crit Rev Oncol\/Hematol. 2017;120:203\u20139.","journal-title":"Crit Rev Oncol\/Hematol"},{"key":"1657_CR36","doi-asserted-by":"publisher","first-page":"205","DOI":"10.12659\/AOT.889188","volume":"18","author":"J Rozga","year":"2013","unstructured":"Rozga J, Pi\u0105tek T, Ma\u0142kowski P. Human albumin: old, new, and emerging applications. Ann Transpl. 2013;18:205\u201317.","journal-title":"Ann Transpl"},{"key":"1657_CR37","doi-asserted-by":"crossref","unstructured":"Giannakeas V, Kotsopoulos J, Brooks JD, Cheung MC, Rosella L, Lipscombe L et al. Platelet count and survival after cancer. Cancers (Basel). 2022;14(3).","DOI":"10.3390\/cancers14030549"},{"issue":"7","key":"1657_CR38","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1056\/NEJMoa1110352","volume":"366","author":"RL Stone","year":"2012","unstructured":"Stone RL, Nick AM, McNeish IA, Balkwill F, Han HD, Bottsford-Miller J, et al. Paraneoplastic thrombocytosis in ovarian cancer. N Engl J Med. 2012;366(7):610\u20138.","journal-title":"N Engl J Med"},{"issue":"45","key":"1657_CR39","doi-asserted-by":"publisher","first-page":"e17475","DOI":"10.1097\/MD.0000000000017475","volume":"98","author":"X Yin","year":"2019","unstructured":"Yin X, Wu L, Yang H, Yang H. Prognostic significance of neutrophil\u2013lymphocyte ratio (NLR) in patients with ovarian cancer: A systematic review and meta-analysis. Medicine. 2019;98(45):e17475.","journal-title":"Medicine"},{"issue":"5","key":"1657_CR40","doi-asserted-by":"publisher","first-page":"e12917","DOI":"10.1111\/eci.12917","volume":"48","author":"C Tian","year":"2018","unstructured":"Tian C, Song W, Tian X, Sun Y. Prognostic significance of platelet-to-lymphocyte ratio in patients with ovarian cancer: A meta-analysis. Eur J Clin Invest. 2018;48(5):e12917.","journal-title":"Eur J Clin Invest"},{"issue":"5","key":"1657_CR41","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1111\/his.15125","volume":"84","author":"JJX Li","year":"2024","unstructured":"Li JJX, Ni SYB, Tsang JYS, Chan WY, Hung RKW, Lui JWH, et al. Neutrophil-lymphocyte ratio reflects tumour-infiltrating lymphocytes and tumour-associated macrophages and independently predicts poor outcome in breast cancers with neoadjuvant chemotherapy. Histopathology. 2024;84(5):810\u201321.","journal-title":"Histopathology"},{"issue":"11","key":"1657_CR42","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.1111\/jog.14427","volume":"46","author":"AA Lertkhachonsuk","year":"2020","unstructured":"Lertkhachonsuk AA, Buranawongtrakoon S, Lekskul N, Rermluk N, Wee-Stekly WW, Charakorn C. Serum CA19-9, CA-125 and CEA as tumor markers for mucinous ovarian tumors. J Obstet Gynaecol Res. 2020;46(11):2287\u201391.","journal-title":"J Obstet Gynaecol Res"},{"key":"1657_CR43","first-page":"3972353","volume":"2018","author":"JJX Li","year":"2018","unstructured":"Li JJX, Lee JHS, Chan VTC, Yu MY. Uterine carcinosarcoma with Alpha-Fetoprotein-Producing hepatoid component: A case report and literature review. Case Rep Pathol. 2018;2018:3972353.","journal-title":"Case Rep Pathol"},{"issue":"1","key":"1657_CR44","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1097\/GCO.0b013e3282f2b124","volume":"20","author":"E H\u00f8gdall","year":"2008","unstructured":"H\u00f8gdall E. Cancer antigen 125 and prognosis. Curr Opin Obstet Gynecol. 2008;20(1):4\u20138.","journal-title":"Curr Opin Obstet Gynecol"},{"issue":"1","key":"1657_CR45","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1186\/s12957-020-01978-6","volume":"18","author":"K Nakamura","year":"2020","unstructured":"Nakamura K, Kitahara Y, Nishimura T, Yamashita S, Kigure K, Ito I, et al. Nadir CA-125 serum levels during neoadjuvant chemotherapy and no residual tumor at interval debulking surgery predict prognosis in advanced stage ovarian cancer. World J Surg Oncol. 2020;18(1):200.","journal-title":"World J Surg Oncol"}],"container-title":["Journal of Ovarian Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-025-01657-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13048-025-01657-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-025-01657-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,10]],"date-time":"2025-05-10T03:55:07Z","timestamp":1746849307000},"score":1,"resource":{"primary":{"URL":"https:\/\/ovarianresearch.biomedcentral.com\/articles\/10.1186\/s13048-025-01657-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,10]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1657"],"URL":"https:\/\/doi.org\/10.1186\/s13048-025-01657-8","relation":{},"ISSN":["1757-2215"],"issn-type":[{"value":"1757-2215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,10]]},"assertion":[{"value":"31 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval was granted by the Joint Chinese University of Hong Kong\u2013 New Territories East Cluster Clinical Research Ethics Committee (reference number 2020.089) with waiver of written informed consent. The research has been performed in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that there is no conflict of interest regarding the publication of this paper.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"98"}}